Can Jamaica Make up for Lost Ground in Cannabis Research Following Decriminalisation?

Warning message

The subscription service is currently unavailable. Please try again later.

Marijuana researchers on the Caribbean island of Jamaica are planning to develop new pharmaceutical products following the partial decriminalisation of cannabis.

Following the partial decriminalisation of cannabis earlier this year, Jamaican scientists are harnessing more than 40 years of research in a bid to cash in on the lucrative global medical marijuana market.

As of April 2015, the possession of two ounces of marijuana, or less, is no longer an arrestable offence in Jamaica and the establishment of a Cannabis Licensing Authority is paving the way for the development of a set of rules and regulations to govern this burgeoning pharmaceutical industry, estimated to be worth US$100 billion worldwide.

As a result, marijuana researchers on the island are hoping to develop new pharmaceutical products, almost four decades after several new medicines were developed and subsequently launched on the international market.

“We are not talking about smoking ganja...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.